成都欧林生物科技股份有限公司2023年限制性股票激励计划首次授予部分第一类限制性股票回购注销实施公告

Core Viewpoint - The company, Chengdu Olin Biological Technology Co., Ltd., has announced the repurchase and cancellation of 224,700 shares of restricted stock due to unmet performance targets in its 2023 stock incentive plan [2][5]. Group 1: Repurchase and Cancellation Details - The repurchase is based on the failure to meet the performance assessment criteria for the second unlock period of the restricted stock incentive plan [2][5]. - The repurchase price is set at 10.59 yuan per share, plus interest at the bank's current deposit rate [3][6]. - The decision was approved by the board of directors on October 28, 2025, and subsequently ratified by the shareholders on November 14, 2025 [3][4]. Group 2: Impact on Share Capital - Following the cancellation, the total share capital will decrease from 405,933,600 shares to 405,708,900 shares, reflecting a reduction of 224,700 shares [8]. - The remaining number of restricted shares for the eight incentive recipients will be 299,600 shares after the cancellation [6]. Group 3: Compliance and Legal Opinions - The company has complied with relevant laws and regulations regarding the decision-making and disclosure processes for the repurchase [9]. - The legal opinion confirms that the repurchase aligns with the company's incentive plan and applicable regulations [9].